Stockscreener 앱 받기
94.14
1.58%
-1.58
전일 마감가:
$95.72
열려 있는:
$95.35
하루 거래량:
2.59M
Relative Volume:
0.30
시가총액:
$139.66B
수익:
$19.35B
순이익/손실:
$2.78B
주가수익비율:
50.35
EPS:
1.8696
순현금흐름:
$3.82B
1주 성능:
-3.66%
1개월 성능:
+1.76%
6개월 성능:
-8.71%
1년 성능:
-0.42%
1일 변동 폭
$93.40
$95.45
1주일 범위
$93.40
$100.90
52주 변동 폭
$85.98
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
94.21 | 141.90B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
123.10 | 216.73B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
356.62 | 138.20B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.77 | 124.29B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.35 | 48.17B | 5.88B | 1.34B | 799.60M | 2.3489 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific wins FDA nod for Farapoint PFA catheter - MassDevice
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Boston Scientific plans 300,000-square-foot expansion at Maple Grove campus - The Business Journals
Boston Scientific to acquire California bladder dysfunction treatment company - Worcester Business Journal
Boston Scientific to Buy Urinary Incontinence Treatment Maker Valencia Technologies - Medical Product Outsourcing
Global Catheters Market Size to Hit USD 55.58 Billion by 2033, Driven by Rising Cardiovascular and Urological Procedures – SNS Insider - GlobeNewswire Inc.
Boston Scientific To Acquire Valencia Technologies - Nasdaq
Boston Scientific to acquire urinary incontinence treatment developer Valencia Technologies - MassDevice
Boston Scientific to acquire Valencia Technologies for urology expansion - Investing.com
A Look At Boston Scientific (BSX) Valuation As Analyst Optimism And Earnings Anticipation Build - Yahoo Finance
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Med tech company Boston Scientific readies for new Austin offices - MSN
Did Analyst Upgrades and Pipeline Optimism Just Shift Boston Scientific's (BSX) Investment Narrative? - Yahoo Finance
Boston Scientific plans move to former Scorpion building - Santa Clarita Valley Signal
Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch - TipRanks
What technical signals suggest for Boston Scientific Corporation stock2025 Trading Recap & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Boston Scientific Corp.: How a Medtech Powerhouse Is Re?Wiring the Future of Minimally Invasive Care - AD HOC NEWS
Boston Scientific reportedly plans to consolidate some Texas operations with new facility - MassDevice
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? - Finviz
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Boston Scientific Earnings Preview: What to Expect - Barchart.com
Can Boston Scientific Corporation stock continue upward trendDividend Aristocrats List & Small Capital Trading Growth - ulpravda.ru
Boston Scientific (BSX) Just Overtook the 50-Day Moving Average - Yahoo Finance
If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now - Yahoo Finance
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
We Think Boston Scientific (NYSE:BSX) Can Manage Its Debt With Ease - Yahoo Finance
Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors - DirectorsTalk Interviews
Boston Scientific Stock: Steady Beat, Subtle Volatility – What The Market Is Really Pricing In - AD HOC NEWS
JARISLOWSKY FRASER Ltd Trims Stake in Boston Scientific Corporation $BSX - MarketBeat
Synergy Asset Management LLC Acquires 479,593 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Is Quietly Winning Wall Street – But Is BSX Actually Worth Your Money? - AD HOC NEWS
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results - Finviz
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results – Company AnnouncementFT.com - Financial Times
A Look Into Boston Scientific Inc's Price Over Earnings - Benzinga
Vanderbilt University Has $2.55 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
List of 56 Acquisitions by Boston Scientific (Jan 2026) - Tracxn
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up? - The Globe and Mail
Calamos Wealth Management LLC Buys 53,252 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Boston Trust Walden Corp - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
Does Boston Scientific (NYSE:BSX) Deserve A Spot On Your Watchlist? - Yahoo Finance
Boston Scientific Corp. stock: quiet tape, loud expectations as Wall Street leans bullish - AD HOC NEWS
Sowell Financial Services LLC Sells 28,806 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Position Lessened by Ethic Inc. - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5 - Quantisnow
A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook - Insider Monkey
VCI Wealth Management LLC Invests $1.26 Million in Boston Scientific Corporation $BSX - MarketBeat
Norden Group LLC Increases Holdings in Boston Scientific Corporation $BSX - MarketBeat
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
자본화:
|
볼륨(24시간):